DNA methylation contributes toward silencing of antioncogenic microRNA-203 in human and canine melanoma cells

Melanoma Research

Volumn 25, Issue 5, 2015, Pages 390-398

  Noguchi, Shunsuke ^a   Mori, Takashi ^c   Nakagawa, Takayuki ^d   Itamoto, Kazuhito ^b   Haraguchi, Tomoya ^b   Mizuno, Takuya ^a  

^a YAMAGUCHI UNIVERSITY   (Japan)

^b Laboratory of Small Animal Clinical Science Surgical Division Joint Faculty of Veterinary Medicine   (Japan)

^c GIFU UNIVERSITY   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

5 aza 2 deoxycitidine; DNA methylation; human and canine; melanoma; microRNA 203

Indexed keywords

BISULFITE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DECITABINE; LUCIFERASE; MICRORNA; MICRORNA 203; UNCLASSIFIED DRUG; AZACITIDINE; MIRN203 MICRORNA, HUMAN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REPRESSION; EPIGENETICS; GENE ACTIVITY; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MELANOMA CELL LINE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPORTER GENE; RNA TRANSCRIPTION; STEADY STATE; UPREGULATION; ANIMAL; CELL CULTURE; DOG; DOG DISEASE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; MELANOCYTE; MELANOMA; METABOLISM; MOUTH TUMOR; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE; VETERINARY;

ANIMALS; AZACITIDINE; CELL LINE, TUMOR; CELLS, CULTURED; DNA METHYLATION; DOG DISEASES; DOGS; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENES, TUMOR SUPPRESSOR; HUMANS; MELANOCYTES; MELANOMA; MICRORNAS; MOUTH NEOPLASMS;

EID: 84941770219     PISSN: 09608931     EISSN: 14735636     Source Type: Journal    
DOI: 10.1097/CMR.0000000000000183     Document Type: Article

References (24)

1. Gillard M, Cadieu E, de Brito C, Abadie J, Vergier B, Devauchelle P, et al. Naturally occurring melanomas in dogs as models for non-UV pathways of human melanomas. Pigment Cell Melanoma Res 2014; 27:90-102.
2. Simpson RM, Bastian BC, Michael HT, Webster JD, Prasad ML, Conway CM, et al. Sporadic naturally occurring melanoma in dogs as a preclinical model for human melanoma. Pigment Cell Melanoma Res 2014; 27:37-47.
3. Eggermont AM, Robert C. New drugs in melanoma: it's a whole new world. Eur J Cancer 2011; 47:2150-2157.
4. Chim CS, Wan TS, Wong KY, Fung TK, Drexler HG, Wong KF. Methylation of miR-34a, miR-34b/c, miR-124-1 and miR-203 in Ph-negative myeloproliferative neoplasms. J Transl Med 2011; 9:197.
5. Chim CS, Wong KY, Leung CY, Chung LP, Hui PK, Chan SY, Yu L. Epigenetic inactivation of the hsa-miR-203 in haematological malignancies. J Cell Mol Med 2011; 15:2760-2767.
6. Wong KY, Liang R, So CC, Jin DY, Costello JF, Chim CS. Epigenetic silencing of MIR203 in multiple myeloma. Br J Haematol 2011; 154:569-578.
7. Sun BS, Dong QZ, Ye QH, Sun HJ, Jia HL, Zhu XQ, et al. Lentiviral-mediated miRNA against osteopontin suppresses tumor growth and metastasis of human hepatocellular carcinoma. Hepatology 2008; 48:1834-1842.
8. Cannell IG, Kong YW, Bushell M. How do microRNAs regulate gene expression? Biochem Soc Trans 2008; 36:1224-1231.
9. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136:215-233.
10. Chiang HR, Schoenfeld LW, Ruby JG, Auyeung VC, Spies N, Baek D, et al. Mammalian microRNAs: experimental evaluation of novel and previously annotated genes. Genes Dev 2010; 24:992-1009.
11. Harfe BD. MicroRNAs in vertebrate development. Curr Opin Genet Dev 2005; 15:410-415.
12. Zhang J, Jima DD, Jacobs C, Fischer R, Gottwein E, Huang G, et al. Patterns of microRNA expression characterize stages of human B-cell differentiation. Blood 2009; 113:4586-4594.
13. Lynam-Lennon N, Maher SG, Reynolds JV. The roles of microRNA in cancer and apoptosis. Biol Rev Camb Philos Soc 2009; 84:55-71.
14. Kaddar T, Rouault JP, Chien WW, Chebel A, Gadoux M, Salles G, et al. Two new miR-16 targets: caprin-1 and HMGA1, proteins implicated in cell proliferation. Biol Cell 2009; 101:511-524.
15. Van Kempen LC, van den Hurk K, Lazar V, Michiels S, Winnepenninckx V, Stas M, et al. Loss of microRNA-200a and c, and microRNA-203 expression at the invasive front of primary cutaneous melanoma is associated with increased thickness and disease progression. Virchows Arch 2012; 461:441-448.
16. Cho WC. MicroRNAs as therapeutic targets and their potential applications in cancer therapy. Expert Opin Ther Targets 2012; 16:747-759.
17. Cho WC. MicroRNAs in cancer-from research to therapy. Biochim Biophys Acta 2010; 1805:209-217.
18. Noguchi S, Kumazaki M, Mori T, Baba K, Okuda M, Mizuno T, Akao Y. Analysis of microRNA-203 function in CREB/MITF/RAB27a pathway: comparison between canine and human melanoma cells. Vet Comp Oncol 2014. [Epub ahead of print].
19. Noguchi S, Mori T, Otsuka Y, Yamada N, Yasui Y, Iwasaki J, et al. Antioncogenic microRNA-203 induces senescence by targeting E2F3 protein in human melanoma cells. J Biol Chem 2012; 287:11769-11777.
20. Noguchi S, Kumazaki M, Yasui Y, Mori T, Yamada N, Akao Y. MicroRNA-203 regulates melanosome transport and tyrosinase expression in melanoma cells by targeting kinesin superfamily protein 5b. J Invest Dermatol 2014; 134:461-469.
21. Noguchi S, Mori T, Hoshino Y, Yamada N, Maruo K, Akao Y. MicroRNAs as tumour suppressors in canine and human melanoma cells and as a prognostic factor in canine melanomas. Vet Comp Oncol 2013; 11:113-123.
22. Noguchi S, Mori T, Hoshino Y, Maruo K, Yamada N, Kitade Y, et al. MicroRNA-143 functions as a tumor suppressor in human bladder cancer T24 cells. Cancer Lett 2011; 307:211-220.
23. Nguyen CT, Weisenberger DJ, Velicescu M, Gonzales FA, Lin JC, Liang G, Jones PA. Histone H3-lysine 9 methylation is associated with aberrant gene silencing in cancer cells and is rapidly reversed by 5-aza-2?-deoxycytidine. Cancer Res 2002; 62:6456-6461.
24. Nie J, Liu L, Li X, W Han. Decitabine, a new star in epigenetic therapy: the clinical application and biological mechanism in solid tumors. Cancer Lett 2014; 354:12-20.